Skip to content

Research and laboratory use only · Not for human, clinical, diagnostic or veterinary use

Sterigenix Medical Inc.
Request access
Glow Blend — 70 mg — Lyophilized powder
BBG70Purity BPC-157 99.05%; GHK-Cu 99.21%; TB-500 99.30%Blends

Glow Blend — 70 mg

Glow Blend is supplied as a lyophilized combination preparation in a sealed vial. Each vial contains 70 mg. Contents: BPC-157, GHK-Cu, TB-500. This product is intended for research and laboratory use only.

Key features

  • Combination preparation
  • 70 mg per vial
  • Lyophilized powder
  • Contents: BPC-157, GHK-Cu, TB-500
  • Purity: BPC-157 99.05%; GHK-Cu 99.21%; TB-500 99.30%
  • Supplied in a sealed vial
  • For research and laboratory use only

Specifications

Type
Combination preparation
Amount
70 mg per vial
Form
Lyophilized powder
Purity
BPC-157 99.05%; GHK-Cu 99.21%; TB-500 99.30%
Storage
Refrigerate at 2–8 °C (see Storage Instructions)
Package Contents
1 × sealed vial (70 mg)
Directions / Recommended Handling
Intended for laboratory research handling only. Reconstitution and handling should follow the end user’s validated research protocol. Not for human or veterinary use.

Storage and handling

Unopened vial

  • Unopened, lyophilized (freeze-dried) peptide vials should be kept in a cool, dark, and dry place.

After reconstitution

  • Store between 2 °C and 8 °C in a standard refrigerator. Do not store in the refrigerator door, due to temperature fluctuations.
  • Use within 3 to 6 months, depending on the peptide type and storage care.
  • Protect from light — wrap the vial in aluminum foil or keep it in a dark, airtight container.
  • Keep the vial upright to prevent the solution from contacting the rubber stopper.
  • Avoid repeated freezing and thawing.

Handling information describes laboratory storage of the material only. It is not guidance for administration or use of any kind.

Certificate of analysis

All certificates

No certificate is published for this product yet. Approved account holders can request the certificate for a specific lot.

More in Blends

BPC-157 + TB-500 — 20 mg Combination Vial — Lyophilized powder
BB20BPC-157 99.78%; TB-500 98.76%

BPC-157 + TB-500 — 20 mg Combination Vial

BPC-157 + TB-500 is supplied as a lyophilized powder in a sealed vial (BPC-157 10 mg + TB-500 10 mg per vial). For research and laboratory use only.

  • Synthetic peptide combination
  • BPC-157 10 mg + TB-500 10 mg per vial
  • Lyophilized powder
SealedPricing is released to approved accounts only.
Request access
CJC-1295 Without DAC + Ipamorelin — 10 mg Combination Vial — Lyophilized powder
CP10CJC-1295 without DAC 98.46%; Ipamorelin 98.20%

CJC-1295 Without DAC + Ipamorelin — 10 mg Combination Vial

CJC-1295 (without DAC) + Ipamorelin is supplied as a lyophilized powder in a sealed vial (CJC-1295 without DAC 5 mg + Ipamorelin 5 mg per vial). For research and laboratory use only.

  • Synthetic peptide combination
  • CJC-1295 without DAC 5 mg + Ipamorelin 5 mg per vial
  • Lyophilized powder
SealedPricing is released to approved accounts only.
Request access
KLOW Combination — 80 mg — Lyophilized powder
KLOW80

KLOW Combination — 80 mg

KLOW Combination is supplied as a lyophilized combination preparation in a sealed vial (80 mg per vial). For research and laboratory use only.

  • Synthetic peptide and copper-peptide combination
  • 80 mg per vial
  • Lyophilized powder
SealedPricing is released to approved accounts only.
Request access